Back to search

United Kingdom· GB-APID-269711000001104

Lederfen 300mg tablets

A fenbufen product containing fenbufen, registered in United Kingdom by Mercury Pharma Group Ltd.

ATC M01AE05

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLederfen 300mg tabletsATCM01AE05REGISTER NO.GB-APID-2697110000011…PACKS LISTED1CHECKEDOctober 2, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Fenbufen
Manufacturer
Mercury Pharma Group Ltd
Country
United Kingdom (GB)
ATC code
M01AE05
ATC class
Fenbufen
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
October 2, 2026

Packs & prices · 1

  • gtin
    5021691164234

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0e0cea4-b210-4352-82f8-9e3bff5a179a
GET /v1/drugs/d0e0cea4-b210-4352-82f8-9e3bff5a179a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "269711000001104",
  "desc": "Lederfen 300mg tablets (Mercury Pharma Group Ltd)",
  "form": "Oral tablet",
  "vpid": "42103811000001106",
  "source": "dmd",
  "vtm_id": "775926008",
  "strength": "300 mg",
  "substance": "Fenbufen",
  "ingredient": "Fenbufen",
  "supplier_code": "151601000001102"
}

See everything about fenbufen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.